Abstract
In the population of older adults, anxiety disorders are underdiagnosed and undertreated. Epidemiologic studies have generally found that the prevalence of anxiety disorders declines with age. Recognition of anxiety disorders in older adults is, however, complicated by several age-related factors including the presence of depression, cognitive impairment, and physical illness. A variety of medications have been used to treat anxiety disorders across the life span; however, few studies have evaluated their use specifically in older adults. Choice of medication requires consideration of the effects of aging on safety, tolerability, and adherence. Available data suggest that cognitive and behavioral treatments may be effective for anxiety disorders in older adults. Appropriate medical evaluation and psychosocial interventions are recommended prior to initiating pharmacotherapy. When pharmacologic treatment is warranted, antidepressant medications at low doses may be useful for late-life anxiety disorders; other agents may be considered for augmentation or second-line use in certain types of patients.
Similar content being viewed by others
References and Recommended Reading
Kessler RC, McGonagle KA, Zhao S, et al.: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994, 51:8–19.
Jeste DV, Alexopoulos GS, Bartels SJ, et al.: Consensus statement on the upcoming crisis in geriatric mental health: research agenda for the next 2 decades. Arch Gen Psychiatry 1999, 56:848–853. This paper describes the current disparity in the availability of psychiatric treatment for older adults relative to their younger counterparts. The authors propose a 15- to 25-year agenda for the research of late-life psychiatric disorders aimed at keeping pace with the projected growth of the population of older adults.
Kennedy BL, Schwab JJ: Utilization of medical specialists by anxiety disorder patients. Psychosomatics 1997, 38:109–112.
Regier DA, Boyd JH, Burke JDJ, et al.: One-month prevalence of mental disorders in the United States: Based on five Epidemiologic Catchment Area sites. Arch Gen Psychiatry 1988, 45:977–986.
Bland RC, Newman SC, Orn H: Prevalence of psychiatric disorders in the elderly in Edmonton. Acta Psychiatr Scand 1988, 338:57–63.
Copeland JRM, Gurland BJ, Dewey ME, et al.: Is there more dementia, depression and neurosis in New York? A comparative study of the elderly in New York and London using the computer diagnosis AGECAT. Br J Psychiatry 1987, 151:466–473.
Bergmann K: The neuroses of old age. In Recent Developments in Psychogeriatrics: A Symposium, British Journal of Psychiatry Special Publication 6. Kent, England: Headley Brothers; 1971.
Beekman ATF, Bremmer MA, Deeg DJH, et al.: Anxiety disorders in later life: a report from the Longitudinal Aging Study Amsterdam. Int J Geriatr Psychiatry 1998, 13:717–726. This study examines the prevalence of five psychiatric disorders in a large random sample of older adults. It provides epidemiologic data about late-life anxiety disorders that are likely more accurate than those reported by previous studies.
Krasucki C, Howard R, Mann A: The relationship between anxiety disorders and age. Int J Geriatr Psychiatry 1998, 13:79–99.
Flint AJ: Anxiety disorders in late life. Can Fam Physician 1999, 45:2672–2679. This article reviews the current epidemiology, clinical characteristics, and treatment of anxiety disorders in older adults. Each of the anxiety disorders is addressed individually, with prevalence data derived from well designed random-sample community surveys.
Lindesay J: Phobic disorders in the elderly. Br J Psychiatry 1991, 159:531–541.
Sutker PB, Allain ANJr, Winstead DK: Psychopathology and psychiatric diagnoses of World War II Pacific theater prisoner of war survivors and combat veterans. Am J Psychiatry 1993, 150:240–245.
Engdahl B, Dikel TN, Eberly R, Blank AJr: Post-traumatic stress disorder in a community group of former prisoners of war: a normative response to severe trauma. Am J Psychiatry 1997, 154:1576–1581.
Kuch K, Cox BJ: Symptoms of PTSD in 124 survivors of the Holocaust. Am J Psychiatry 1992, 149:337–340.
Robinson S, Rapaport J, Durst R, et al.: The late effects of Nazi persecution among elderly Holocaust survivors. Acta Psychiatr Scand 1990, 82:311–315.
Shapiro AM, Roberts JE, Beck JG: Differentiating symptoms of anxiety and depression in older adults: distinct cognitive and affective profiles? Cog Ther Res 1999, 33:53–74.
Kogan JN, Edelstein BA, McKee DR: Assessment of anxiety in older adults: Current status. J Anxiety Disorders 2000, 14:109–132.
Palmer BW, Jeste DV, Sheikh JI: Anxiety disorders in the elderly: DSM-IV and other barriers to diagnosis and treatment. J Affective Disord 1997, 46:183–190.
Flint AJ: Epidemiology and comorbidity of anxiety disorders in the elderly. Am J Psychiatry 1994, 151:640–649.
Sheikh JI, King RJ, Taylor CB: Comparative phenomenology of early-onset versus late-onset panic attacts: a pilot survey. Am J Psychiatry 1991, 148:1231–1233.
Goenjian AK, Najarian LM, Pynoos RS, et al.: Post-traumatic stress disorder in elderly and younger adults after the 1988 earthquake in Armenia. Am J Psychiatry 1994, 151:895–901.
Flint AJ: Management of anxiety in late life. J Geriatr Psychiatry Neurol 1998, 11:194–200.
Beekman ATF, de Beurs E, van Balkom AJLM: Anxiety and depression in later life: co-occurrence and communality of risk factors. Am J Psychiatry 2000, 157:89–95. This study examines the comorbidity of anxiety and depression in older adults. High levels of comorbidity are reported, and a distinct risk factor profile tends to apply to persons who are affected by both major depression as well as an anxiety disorder concurrently.
Manela M, Katona C, Livingston G: How common are the anxiety disorders in old age? Int J Geriatr Psychiatry 1996, 11:65–70.
Lenze EJ, Mulsant BH, Shear MK, et al.: Comorbid anxiety disorders in depressed elderly patients. Am J Psychiatry 2000, 157:722–728.
Parmelee PA, Katz IR, Lawton MP: Anxiety and its association with depression among institutionalized elderly. Am J Geriatr Psychiatry 1993, 1:46–58.
Hassan R, Pollard A: Late-life-onset panic disorder: clinical and demographic characteristics of a patient sample. J Geriatr Psychiatry Neurol 1994, 7:86–90.
Livingston HM, Livingston MG, Fell S: The Lockerbie disaster: a 3-year follow-up of elderly victims. Int J Geriatr Psychiatry 1994, 9:989–994.
Flint AJ, Rifat SL: Two-year outcome of elderly patients with anxious depression. Psychiatry Res 1997, 66:223–31.
Robins LN, Regier DA: Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York: The Free Press; 1991.
Teri L, Ferretti LE, Gibbons LE, et al.: Anxiety in Alzheimer’s disease: prevalence and comorbidity. J Gerontol 1999, 54:M348-M352.
Forsell Y, Winblad B: Anxiety disorders in non-demented and demented elderly patients: prevalence and correlates. J Neurol Neurosurg Psych 1997, 62:294–295.
Astrom M: Generalized anxiety disorder in stroke patients: a 3-year longitudinal study. Stroke 1996, 27:270–275.
Sembi S, Tarrier N, O’Neill P, et al.: Does post-traumatic stress disorder occur after stroke: a preliminary study. Int J Geriatr Psychiatry 1998, 13:315–322.
Jonas BS, Franks P, Ingram DD: Are symptoms of anxiety and depression risk factors for hypertension? Arch Fam Med 1997, 6:43–49.
Kawachi I, Sparrow D, Vokonas PS, Weiss ST: Symptoms of anxiety and risk of coronary heart disease: the normative aging study. Circulation 1994, 90:2225–2229.
Von Moltke LL, Abernethy DR, Greenblatt DJ: Kinetics and dynamics of psychotropic drugs in the elderly. In Clinical Geriatric Psychopharmacology. edn 3. Edited by Salzman C. Baltimore, MD: Williams & Wilkins; 1998:70–93.
Small GW: Recognizing and treating anxiety in the elderly. J Clin Psychiatry 1997, 58(suppl):41–47.
Salzman C: Pharmacologic treatment of the anxious elderly patient. In Anxiety in the Elderly: Treatment and Research. Edited by Salzman C, Lebowitz BD. New York: Springer; 1991:149–173.
Herings RMC, Stricker BHC, de Boer A, et al.: Benzodiazepines and the risk of falling leading to femur fractures. Arch Internal Med 1995, 155:1801–1807.
Ray WA, Thapa PB, Gideon P: Benzodiazepines and the risk of falls in nursing home residents. J Am Ger Society 2000, 48:682–685.
Hanlon JT, Horner RD, Schmader KE, et al.: Benzodiazepine use and cognitive function among community-dwelling elderly. Clin Pharmacol Therap 1998, 64:684–692.
Sheikh JI, Cassidy EL: Treatment of anxiety disorders in the elderly: issues and strategies. J Anxiety Disorders 2000, 14:173–190. This article provides specific treatment strategies for the various anxiety disorders in later life. First-line and second-line treatment alternatives are described, incorporating both pharmacotherapy and cognitive-behavioral therapy, where appropriate.
Schneider LS: Overview of generalized anxiety disorder in the elderly. J Clin Psychiatry 1996, 57(suppl):34–45.
Steinberg JR: Anxiety in elderly patients: a comparison of azapirones and benzodizepines. Drugs Aging 1994. 5:335–345.
Bohm C, Robinson DS, Gammans RE, et al.: Buspirone therapy in anxious elderly patients: a controlled clinical trail. J Clin Psychopharmacol 1990, 10(suppl):S47-S51.
Rocca P, Fonzo V, Scotta M, et al.: Paroxetine efficacy in the treatment of generalized anxiety disorder. Acta Psychiatr Scand 1997, 95:444–450.
Katzelnick DJ, Kobak KA, Greist JH, et al.: Sertraline for social phobia: a double-blind, placebo-controlled crossover study. Am J Psychiatry 1995, 152:1368–1371.
Koran LM, McElroy SL, Davidson JR, et al.: Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a doubleblind comparison. J Clin Psychopharm 1996, 16:121–129.
Wylie ME, Miller MD, Shear MK, et al.: Fluvoxamine pharmacotherapy of anxiety disorders in later life: preliminary open-trial data. J Ger Psych Neurolog 2000, 13:43–48.
De Boer M, Op den Velde W, Falger PJR, et al.: Fluvoxamine treatment for chronic PTSD—a pilot study. Psychother Psychosom 1992, 57:158–163.
Calamari JE, Faber SD, Hitsman BL, Poppe CJ: Treatment of obsessive compulsive disorder in the elderly: a review and case example. J Behav Ther Exp Psychiatry 1994, 25:95–104.
Nutt D: Early action of nefazodone in anxiety associated with depression. J Psychopharmacolog 1996, 10(suppl):18–21.
Marazziti D, Pallant S: Effectiveness of olanzapine treatment for severe obsessive-compulsive disorder. Am J Psychiatry 1999, 153:1834–1835.
McDougle CJ, Epperson CN, Pelton GH, et al.: A double-blind, placebo-controlled study of risperidone addition to serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 2000, 57:794–801.
Chambless DL, Gillis MM: Cognitive therapy of anxiety disorders. J Consult Clin Psychology 1993, 61:248–260.
Carmin CN, Pollard CA, Ownby RL: Cognitive behavioral treatment of older versus younger adults with OCD. Clin Gerontol 1998, 19:77–81.
Swales PJ, Soljin JF, Sheikh JI: Cognitive-behavioral therapy in older panic disorder patients. Am J Psychiatry 1996, 4:46–60.
Tennstedt S, Howland J, Lachman M, et al.: A randomized, controlled trial of a group intervention to reduce fear of falling and associated activity restriction in older adults. J Gerontol 1998, 53B:384–392.
Stanley MA, Beck JG, Glassco JD: Treatment of generalized anxiety in older adults: a preliminary comparison of cognitive-behavioral and supportive approaches. Behav Ther 1996, 27:565–581.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sable, J.A., Jeste, D.V. Anxiety disorders in older adults. Curr Psychiatry Rep 3, 302–307 (2001). https://doi.org/10.1007/s11920-001-0023-0
Issue Date:
DOI: https://doi.org/10.1007/s11920-001-0023-0